Gadd 45 in the Response of Hematopoietic Cells to Stress

Gadd 45 在造血细胞对应激反应中的作用

基本信息

  • 批准号:
    7886593
  • 负责人:
  • 金额:
    $ 37.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-15 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Gadd45 proteins are key players in cellular stress responses. These proteins interact with cell cycle & stress response proteins, including PCNA, p21, Cdc2/cyclinB1, MEKK4 & p38 kinase. Taking advantage of the gadd45 null mice several important observations have been made. This includes evidence that gadd45 genes play an important role in regulating the response of hematopoietic cells to genotoxic & physiological stress, including acute stimulation by hematopoietic cytokines, myeloablating agents & inflammatory substances. The unifying hypothesis is that Gadd45 proteins are modulators of interrelated hematopoietic stress signaling pathways in response to genotoxic & physiological stimuli, and have distinct roles in sub-compartments of the hematopoietic cascade; in addition, Gadd45 functions are manifested by binding to partner proteins implicated in stress signaling. Gadd45a and Gadd45b play pro-survival roles, protecting myeloid cells from genotoxic stress induced cell death, including ultraviolet-radiation (UV), VP-16 & daunorubicin (DNR). Aim 1 is targeted at elucidating signaling pathways via which Gadd45 proteins protect myeloid cells from genotoxic stress. Evidence was obtained that Gadd45a & Gadd45b modulate survival & differentiation of myeloid progenitors in response to acute stimulation with differentiating cytokines. Experiments proposed in Aim 2 are targeted at assessing how Gadd45 proteins interact with partners to regulate the program of terminal differentiation following acute stimulation with differentiating cytokines, conditions that mimic what occurs during inflammatory stress. Preliminary evidence shows that Gadd45b and Gadd45a also modulate the function of hematopoietic stem cells (HSC). Aim 3 will determine what role(s) these Gadd45 proteins play in modulating HSC functions. This research plan should result in increased understanding of stress responses of hematopoietic cells, & set the stage to evaluate, in clinically relevant settings, the impact the status of Gadd45 proteins has on the efficacy of chemotherapeutic agents & anti inflammatory drugs.
描述(由申请人提供):Gadd 45蛋白是细胞应激反应的关键参与者。这些蛋白与细胞周期和应激反应蛋白相互作用,包括PCNA,p21,Cdc 2/cyclinB 1,MEKK 4和p38激酶。利用gadd 45缺失小鼠,已经进行了几个重要的观察。这包括gadd 45基因在调节造血细胞对遗传毒性和生理应激的反应中起重要作用的证据,包括造血细胞因子,骨髓清除剂和炎症物质的急性刺激。统一的假设是,Gadd 45蛋白是响应于遗传毒性和生理刺激的相关造血应激信号传导途径的调节剂,并且在造血级联的子区室中具有不同的作用;此外,Gadd 45功能通过与应激信号传导中涉及的伴侣蛋白结合来表现。Gadd 45 a和Gadd 45 b发挥促存活作用,保护骨髓细胞免受遗传毒性应激诱导的细胞死亡,包括紫外线辐射(UV)、VP-16和柔红霉素(DNR)。目的1旨在阐明Gadd 45蛋白通过其保护骨髓细胞免受遗传毒性应激的信号通路。获得了Gadd 45 a和Gadd 45 b响应于分化细胞因子的急性刺激而调节骨髓祖细胞的存活和分化的证据。目标2中提出的实验旨在评估Gadd 45蛋白如何与伴侣相互作用以调节用分化细胞因子急性刺激后的终末分化程序,所述分化细胞因子是模拟炎症应激期间发生的情况的条件。初步证据表明,Gadd 45 b和Gadd 45 a也调节造血干细胞(HSC)的功能。目的3将确定这些Gadd 45蛋白在调节HSC功能中起什么作用。这项研究计划应该会增加对造血细胞应激反应的理解,并为在临床相关环境中评估Gadd 45蛋白的状态对化疗药物和抗炎药物疗效的影响奠定基础。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAN A LIEBERMANN其他文献

DAN A LIEBERMANN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAN A LIEBERMANN', 18)}}的其他基金

Gadd45 stress sensors in leukemia
白血病中的 Gadd45 应激传感器
  • 批准号:
    8450704
  • 财政年份:
    2012
  • 资助金额:
    $ 37.5万
  • 项目类别:
Gadd45 stress sensors in leukemia
白血病中的 Gadd45 应激传感器
  • 批准号:
    8623106
  • 财政年份:
    2012
  • 资助金额:
    $ 37.5万
  • 项目类别:
Gadd45 stress sensors in leukemia
白血病中的 Gadd45 应激传感器
  • 批准号:
    8824839
  • 财政年份:
    2012
  • 资助金额:
    $ 37.5万
  • 项目类别:
Gadd 45 genes sensors of stress and tumor modulators
Gadd 45 应激基因传感器和肿瘤调节剂
  • 批准号:
    8138188
  • 财政年份:
    2007
  • 资助金额:
    $ 37.5万
  • 项目类别:
Gadd 45 in the Response of Hematopoietic Cells to Stress
Gadd 45 在造血细胞对应激反应中的作用
  • 批准号:
    7642402
  • 财政年份:
    2007
  • 资助金额:
    $ 37.5万
  • 项目类别:
Gadd 45 genes sensors of stress and tumor modulators
Gadd 45 应激基因传感器和肿瘤调节剂
  • 批准号:
    8037805
  • 财政年份:
    2007
  • 资助金额:
    $ 37.5万
  • 项目类别:
Gadd 45 in the Response of Hematopoietic Cells to Stress
Gadd 45 在造血细胞对应激反应中的作用
  • 批准号:
    7316879
  • 财政年份:
    2007
  • 资助金额:
    $ 37.5万
  • 项目类别:
Gadd 45 genes sensors of stress and tumor modulators
Gadd 45 应激基因传感器和肿瘤调节剂
  • 批准号:
    7409585
  • 财政年份:
    2007
  • 资助金额:
    $ 37.5万
  • 项目类别:
Gadd 45 genes sensors of stress and tumor modulators
Gadd 45 应激基因传感器和肿瘤调节剂
  • 批准号:
    7766969
  • 财政年份:
    2007
  • 资助金额:
    $ 37.5万
  • 项目类别:
Gadd 45 genes sensors of stress and tumor modulators
Gadd 45 应激基因传感器和肿瘤调节剂
  • 批准号:
    7575659
  • 财政年份:
    2007
  • 资助金额:
    $ 37.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了